Tearsheet

HealthStream (HSTM)

Market Price (5/23/2026): $23.79 | Market Cap: $698.9 Mil
Sector: Health Care | Industry: Health Care Technology

HealthStream (HSTM)

Market Price (5/23/2026): $23.79
Market Cap: $698.9 Mil
Sector: Health Care
Industry: Health Care Technology

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Attractive cash flow generation
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10%

Low stock price volatility
Vol 12M is 30%

Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.

Weak multi-year price returns
2Y Excs Rtn is -53%, 3Y Excs Rtn is -78%

Expensive valuation multiples
P/EBITPrice/EBIT or Price/(Operating Income) ratio is 30x, P/EPrice/Earnings or Price/(Net Income) is 35x

Key risks
HSTM key risks include [1] execution and operational challenges in its strategic transition to a Platform-as-a-Service architecture and [2] technology scaling issues, Show more.

0	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 20%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is 10%
1	Low stock price volatility Vol 12M is 30%
2	Megatrend and thematic drivers Megatrends include Digital Health & Telemedicine, and Cloud Computing. Themes include Health Data Analytics, AI in Healthcare Management, Show more.
3	Weak multi-year price returns 2Y Excs Rtn is -53%, 3Y Excs Rtn is -78%
4	Expensive valuation multiples P/EBITPrice/EBIT or Price/(Operating Income) ratio is 30x, P/EPrice/Earnings or Price/(Net Income) is 35x
5	Key risks HSTM key risks include [1] execution and operational challenges in its strategic transition to a Platform-as-a-Service architecture and [2] technology scaling issues, Show more.

Valuation, Metrics & Events

	5/23/26	2025	2024	2023	2022
Share Price CYE	$23.79	$23.07	$31.80	$27.03	$24.84
Market Cap CYE ($ Mil)	698.9	683.3	967.4	819.7	759.5
Total Debt ($ Mil)	14.1	14.7	17.4	20.2	23.3
Total Cash ($ Mil)	66.5	57.0	97.2	71.1	53.9
Enterprise Value ($ Mil)	646.4	698.0	984.8	839.9	782.8
Valuation Ratios
P/S TTM	2.2	2.2	3.3	2.9	2.8
P/EBIT TTM	29.9	33.8	45.4	51.2	61.0
P/E TTM	35.1	37.3	48.3	53.9	62.8
P/FCF TTM	21.4	21.9	32.8	22.8	29.1
Sector Ratios
P/S TTM (Sector)	3.7	4.2	3.8	4.2	4.5
P/EBIT TTM (Sector)	-1.8	-1.7	-1.5	-1.5	-1.3
P/E TTM (Sector)	-2.0	-1.8	-1.7	-1.6	-1.3
P/FCF TTM (Sector)	-1.9	-1.8	-1.5	-1.4	-1.6

	5/23/26	2025	2024
Share Price CYE	$23.79	$23.07	$31.80
Market Cap CYE ($ Mil)	698.9	683.3	967.4
Total Debt ($ Mil)	14.1	14.7	17.4
Total Cash ($ Mil)	66.5	57.0	97.2
Enterprise Value ($ Mil)	646.4	698.0	984.8
Valuation Ratios
P/S TTM	2.2	2.2	3.3
P/EBIT TTM	29.9	33.8	45.4
P/E TTM	35.1	37.3	48.3
P/FCF TTM	21.4	21.9	32.8
Sector Ratios
P/S TTM (Sector)	3.7	4.2	3.8
P/EBIT TTM (Sector)	-1.8	-1.7	-1.5
P/E TTM (Sector)	-2.0	-1.8	-1.7
P/FCF TTM (Sector)	-1.9	-1.8	-1.5

	HSTM	S&P 500
REVENUE GROWTH	FAIR
Rev LTM ($ Bil)	0.3
Rev Chg Q	10.5%	8.7%
Rev Chg LTM	6.6%	7.4%
Rev Chg 3Y Avg	4.9%	5.8%
PROFITABILITY	FAIR
Op Inc LTM ($ Bil)	0.0
CFO LTM ($ Bil)	0.1
Net Inc LTM ($ Bil)	0.0
Op Mgn LTM	7.5%	18.4%
CFO/Rev LTM	20.3%	21.1%
Net Inc Mgn	6.4%	13.0%
VALUATION	MODERATE
P/S	2.2	3.2
P/CFO	11.0	15.0
P/FCF	21.4	19.4
P/E	35.1	23.5
STABILITY	VERY GOOD
Debt/Equity	0.02	0.22
Cash/Assets	0.13	0.07

AI Analysis | Feedback

Metric	Value	Date	Source
Recurring Revenue Percentage	97%	11062025	Link
Contracted subscriptions to hStream	5.79 million	12312023	Link
Nurse Grid monthly active users	over 660,000	11042025	Link
My Clinical Exchange users (clinical students)	over 250,000	11042025	Link
HealthStream Learning Center single-day completions	586307	9302025	Link

Recent
5/18/2026	Dividend	Amount: $0.04 Payment On: 5/29/2026

Price Chart

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Analysis | Feedback

HealthStream (HSTM) stock has gained about 5% since 1/31/2026 because of the following key factors:

1. Strong First Quarter 2026 Financial Results: HealthStream announced record revenues of $81.2 million for the first quarter ended March 31, 2026, representing a 10.5% increase compared to the first quarter of 2025. The company also reported record adjusted EBITDA of $20.1 million, up 24.1% year-over-year, and exceeded analyst earnings per share (EPS) expectations by 17.65%, posting $0.20 per share against an estimated $0.17.

2. Reaffirmed Positive Full-Year 2026 Financial Guidance: Following its strong Q1 performance, HealthStream reaffirmed its previously announced full-year 2026 guidance. The company continues to anticipate consolidated revenues between $323 million and $330 million, and adjusted EBITDA between $73 million and $77 million, indicating ongoing confidence in its growth trajectory.

Show more

Holding a concentrated position? Know your true downside before the momentum shifts.

Protect Your Wealth →

Stock Movement Drivers

Fundamental Drivers

The 7.2% change in HSTM stock from 1/31/2026 to 5/22/2026 was primarily driven by a 10.2% change in the company's P/E Multiple.

(LTM values as of)	1312026	5222026	Change
Stock Price ($)	22.22	23.81	7.2%
Change Contribution By:
Total Revenues ($ Mil)	299	312	4.4%
Net Income Margin (%)	6.9%	6.4%	-7.8%
P/E Multiple	31.9	35.1	10.2%
Shares Outstanding (Mil)	30	29	1.1%
Cumulative Contribution			7.2%

LTM = Last Twelve Months as of date shown

Market Drivers

1/31/2026 to 5/22/2026

	Return	Correlation
HSTM	7.2%
Market (SPY)	8.1%	7.4%
Sector (XLV)	-2.7%	10.2%

Fundamental Drivers

The -2.8% change in HSTM stock from 10/31/2025 to 5/22/2026 was primarily driven by a -7.3% change in the company's Net Income Margin (%).

(LTM values as of)	10312025	5222026	Change
Stock Price ($)	24.49	23.81	-2.8%
Change Contribution By:
Total Revenues ($ Mil)	295	312	5.6%
Net Income Margin (%)	6.9%	6.4%	-7.3%
P/E Multiple	36.5	35.1	-3.8%
Shares Outstanding (Mil)	30	29	3.2%
Cumulative Contribution			-2.8%

LTM = Last Twelve Months as of date shown

Market Drivers

10/31/2025 to 5/22/2026

	Return	Correlation
HSTM	-2.8%
Market (SPY)	9.9%	11.2%
Sector (XLV)	4.8%	15.8%

Fundamental Drivers

The -28.7% change in HSTM stock from 4/30/2025 to 5/22/2026 was primarily driven by a -30.9% change in the company's P/E Multiple.

(LTM values as of)	4302025	5222026	Change
Stock Price ($)	33.41	23.81	-28.7%
Change Contribution By:
Total Revenues ($ Mil)	292	312	6.9%
Net Income Margin (%)	6.9%	6.4%	-6.9%
P/E Multiple	50.8	35.1	-30.9%
Shares Outstanding (Mil)	30	29	3.6%
Cumulative Contribution			-28.7%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2025 to 5/22/2026

	Return	Correlation
HSTM	-28.7%
Market (SPY)	36.0%	21.3%
Sector (XLV)	8.6%	25.1%

Fundamental Drivers

The -1.9% change in HSTM stock from 4/30/2023 to 5/22/2026 was primarily driven by a -44.1% change in the company's P/E Multiple.

(LTM values as of)	4302023	5222026	Change
Stock Price ($)	24.28	23.81	-1.9%
Change Contribution By:
Total Revenues ($ Mil)	270	312	15.3%
Net Income Margin (%)	4.4%	6.4%	46.1%
P/E Multiple	62.8	35.1	-44.1%
Shares Outstanding (Mil)	31	29	4.1%
Cumulative Contribution			-1.9%

LTM = Last Twelve Months as of date shown

Market Drivers

4/30/2023 to 5/22/2026

	Return	Correlation
HSTM	-1.9%
Market (SPY)	86.3%	28.9%
Sector (XLV)	18.0%	28.0%

Return vs. Risk

Price Returns Compared

	2021	2022	2023	2024	2025	2026	Total [1]
Returns
HSTM Return	21%	-6%	9%	18%	-27%	3%	10%
Peers Return	32%	-20%	37%	31%	-11%	-22%	33%
S&P 500 Return	27%	-19%	24%	23%	16%	9%	98%
Monthly Win Rates [3]
HSTM Win Rate	67%	42%	50%	50%	50%	40%
Peers Win Rate	57%	37%	60%	68%	43%	32%
S&P 500 Win Rate	75%	42%	67%	75%	67%	60%
Max Drawdowns [4]
HSTM Max Drawdown	-24%	-28%	-25%	-13%	-32%	-14%
Peers Max Drawdown	-16%	-35%	-17%	-17%	-32%	-36%
S&P 500 Max Drawdown	-5%	-25%	-10%	-8%	-19%	-9%

[1] Cumulative total returns since the beginning of 2021
[2] Peers: WDAY, ORCL, NOW, ADP, PAYX.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 5/22/2026 (YTD)

Event	HSTM	S&P 500
Summer-Fall 2023 Five Percent Yield Shock
% Loss	-10.3%	-9.5%
% Gain to Breakeven	11.4%	10.5%
Time to Breakeven	42 days	24 days
2022 Inflation Shock & Fed Tightening
% Loss	-28.2%	-24.5%
% Gain to Breakeven	39.3%	32.4%
Time to Breakeven	391 days	427 days
2020 COVID-19 Crash
% Loss	-22.7%	-33.7%
% Gain to Breakeven	29.4%	50.9%
Time to Breakeven	420 days	140 days
Q4 2018 Fed Policy Error / Growth Scare
% Loss	-22.5%	-19.2%
% Gain to Breakeven	29.0%	23.8%
Time to Breakeven	953 days	105 days
2016-2017 Trump Reflation Bond Selloff
% Loss	-19.9%	-3.7%
% Gain to Breakeven	24.8%	3.9%
Time to Breakeven	92 days	6 days
2015-2016 China Devaluation / Global Growth Scare
% Loss	-29.3%	-12.2%
% Gain to Breakeven	41.5%	13.9%
Time to Breakeven	143 days	62 days

Compare to WDAY, ORCL, NOW, ADP, PAYX

In The Past

HealthStream's stock fell -1.5% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 1.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

Event	HSTM	S&P 500
2022 Inflation Shock & Fed Tightening
% Loss	-28.2%	-24.5%
% Gain to Breakeven	39.3%	32.4%
Time to Breakeven	391 days	427 days
2020 COVID-19 Crash
% Loss	-22.7%	-33.7%
% Gain to Breakeven	29.4%	50.9%
Time to Breakeven	420 days	140 days
Q4 2018 Fed Policy Error / Growth Scare
% Loss	-22.5%	-19.2%
% Gain to Breakeven	29.0%	23.8%
Time to Breakeven	953 days	105 days
2015-2016 China Devaluation / Global Growth Scare
% Loss	-29.3%	-12.2%
% Gain to Breakeven	41.5%	13.9%
Time to Breakeven	143 days	62 days
2014-2016 Oil Price Collapse
% Loss	-29.9%	-6.8%
% Gain to Breakeven	42.6%	7.3%
Time to Breakeven	145 days	15 days
2011 US Debt Ceiling Crisis & European Contagion
% Loss	-25.0%	-17.9%
% Gain to Breakeven	33.3%	21.8%
Time to Breakeven	65 days	123 days
2008-2009 Global Financial Crisis
% Loss	-47.0%	-53.4%
% Gain to Breakeven	88.8%	114.4%
Time to Breakeven	158 days	1085 days
Summer 2007 Credit Crunch
% Loss	-22.9%	-8.6%
% Gain to Breakeven	29.8%	9.5%
Time to Breakeven	53 days	47 days

Compare to WDAY, ORCL, NOW, ADP, PAYX

In The Past

HealthStream's stock fell -1.5% during the 2024 Yen Carry Trade Unwind. Such a loss loss requires a 1.5% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About HealthStream (HSTM)

Business Description Analogies Products Customers Suppliers Management Key Risks Emerging Threats Market Size Revenue Drivers Capital Allocation

HealthStream, Inc. provides workforce and provider solutions for healthcare organizations in the United States. It operates through two segments, Workforce Solutions and Provider Solutions. The company offers workforce solutions, including software-as-a-service (SaaS) based services and subscription-based solutions to meet the range of its clinical development, talent management, training, education, certification, scheduling, competency assessment, performance appraisal, and other needs, as well as implementation and account management services. It also provides applications for learning, performance appraisal, competency management, disclosure management, clinical assessment and development, simulation-based education, quality management, and industry training. In addition, the company offers VerityStream that delivers enterprise-class solutions to transform the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, medical groups, and other healthcare organizations; EchoCredentialing and MSOW platforms that manage medical staff credentialing, enrollment, and privileging processes for hospitals; and EchoOneApp, a provider enrollment platform for medical groups. Further, it provides CredentialMyDoc, a credentialing and enrollment SaaS solution for medical groups and surgery centers; CredentialStream, a SaaS-based provider credentialing, privileging, and enrollment solution; and NurseGrid Mobile for nurse managers. The company offers its solutions in healthcare industry companies that include private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through direct sales teams. HealthStream, Inc. was incorporated in 1990 and is headquartered in Nashville, Tennessee.

AI Analysis | Feedback

HealthStream is like Workday or SAP SuccessFactors, but specialized for the comprehensive human resources, talent management, and compliance needs of healthcare organizations.

HealthStream is like LinkedIn Learning or Cornerstone OnDemand, but exclusively focused on the professional development, clinical training, and certification of healthcare workers.

AI Analysis | Feedback

Workforce Management & Development Platform: Offers SaaS solutions for clinical development, talent management, training, education, certification, scheduling, and competency assessment for healthcare staff.
NurseGrid Mobile: A mobile application designed to assist nurse managers with scheduling and other workforce needs.
VerityStream: An enterprise-class solution that optimizes the healthcare provider experience for ambulatory surgery centers, urgent care facilities, clinics, and medical groups.
EchoCredentialing & MSOW: Platforms specifically designed for hospitals to manage medical staff credentialing, enrollment, and privileging processes.
CredentialStream: A comprehensive SaaS-based solution for provider credentialing, privileging, and enrollment across various healthcare organizations.
CredentialMyDoc & EchoOneApp: SaaS solutions tailored for medical groups and surgery centers for efficient provider credentialing and enrollment.

AI Analysis | Feedback

HealthStream (HSTM) primarily sells its workforce and provider solutions to other companies within the healthcare industry.

Based on the provided company description, specific names of major customer companies are not listed. However, the company serves the following categories of organizations:

Healthcare organizations, which include private, not-for-profit, and government entities.
Pharmaceutical companies.
Medical device companies.

AI Analysis | Feedback

Amazon.com, Inc. (AMZN)

AI Analysis | Feedback

Robert A. Frist, Jr., Chief Executive Officer and Chairman of the Board

Robert A. Frist, Jr. co-founded HealthStream in 1990 and has served as its Chief Executive Officer and Chairman of the Board of Directors since its inception. Under his leadership, HealthStream grew from a dot-com startup into the nation's largest ecosystem of SaaS-based workforce and provider solutions for the healthcare industry. He has been recognized as "Entrepreneur of the Year" for the southeastern region by Ernst & Young and has been named one of the "Most Admired CEOs" among public companies multiple times. Mr. Frist is also a co-founder of Nashville's Entrepreneur Center, where he currently serves as Chairman of the Board, and is a former Chairman of the Nashville Health Care Council. He earned a Bachelor of Science degree in business from Trinity University.

Scott A. Roberts, Chief Financial Officer and Senior Vice President, Accounting and Finance

Scott A. Roberts joined HealthStream in 2002. He progressed through several roles within the Finance and Accounting Department before being promoted to Vice President, Accounting and Finance in January 2015. He was appointed Interim Chief Financial Officer in February 2019 and officially named Chief Financial Officer and Senior Vice President, Accounting and Finance in September 2019. In his current role, Mr. Roberts is responsible for overseeing all of the Company's financial functions, including accounting, audit, financial reporting, treasury management, and corporate finance. He holds a Bachelor of Business Administration degree in Accounting from Middle Tennessee State University.

M. Scott McQuigg, Senior Vice President, Digital & Network Development

Scott McQuigg joined HealthStream in 2019. He is focused on advancing the company's business-to-professional channel and expanding relationships with healthcare professionals. Before joining HealthStream, Mr. McQuigg was the co-founder and Chief Executive Officer of GoNoodle. Prior to GoNoodle, he also co-founded and served as Chief Executive Officer of HealthLeaders, a prominent media, publishing, and research business in the healthcare sector. He has a background as an entrepreneur, having founded several venture-backed businesses in health information and health education.

Michael M. Collier, Executive Vice President, Corporate Strategy, Development and Operations

Michael M. Collier serves as the Executive Vice President of Corporate Strategy, Development and Operations at HealthStream. He is 49 years old.

Kevin P. O'Hara, Executive Vice President, Workforce Platform & Applications

Kevin O'Hara re-joined HealthStream in 2021 and has since been promoted to Executive Vice President, Workforce Platform & Applications. In this role, he is responsible for the company’s hStream platform and core application suites in learning, credentialing, and scheduling. Earlier in his career, Mr. O'Hara began as an attorney and held senior leadership roles at HealthStream from 2001 to 2011. For a decade after that, he served as Chief Executive Officer of Syus, a healthcare IT company, before returning to HealthStream. He holds a Bachelor of Arts degree in Public Policy from Vanderbilt University and a J.D. from the Vanderbilt University School of Law.

AI Analysis | Feedback

The key risks for HealthStream (HSTM) include the potential for AI disruption, margin compression due to rising costs, and challenges associated with the transition away from legacy products.

AI Disruption and Competition: HealthStream operates in the healthcare technology sector, which is characterized by rapid innovation and intense competition. Investors have expressed concerns about the potential for AI to disrupt software-as-a-service (SaaS) firms, including HealthStream. While management suggests their focus on the healthcare workforce may offer some insulation, AI disruption remains a significant "overhang" and a "bearish view" for the company.
Margin Compression and Rising Costs: HealthStream has faced challenges with margin compression, evidenced by a decline in its net margin from 6.9% to 6.0%. Analysts suggest that rising costs and the attrition of legacy products could continue to squeeze profitability. Gross margins are specifically pressured by higher cloud hosting and software licensing costs, in addition to the expenses related to integrating acquired companies.
Legacy Product Attrition and Transition Risks: The company is actively transitioning from older, legacy solutions to newer SaaS platforms. Legacy revenues are declining and currently constitute approximately 10% of total revenues, with management planning to eventually sunset these offerings. This transition introduces "execution risks tied to the contract restructuring and ongoing IT system upgrade costs."

AI Analysis | Feedback

null

AI Analysis | Feedback

```html

For HealthStream (HSTM), the addressable markets for its main products and services are substantial, primarily within the healthcare industry.

Workforce Solutions Segment

HealthStream's Workforce Solutions segment, which includes software-as-a-service (SaaS) based services for clinical development, talent management, training, education, certification, scheduling, competency assessment, and performance appraisal, aligns with the broader healthcare workforce management and learning management systems markets.

The **global healthcare workforce management systems market** was estimated at USD 2.29 billion in 2025 and is projected to reach USD 6.26 billion by 2035, growing at a CAGR of 10.60% from 2026-2035. Another estimate placed the global market at USD 6.2 billion in 2024, with a projection to reach USD 14.5 billion by 2030, at a CAGR of 12.1%.
In the **U.S., the healthcare workforce management systems market** was estimated at USD 0.92 billion in 2025 and is expected to reach USD 2.51 billion by 2035, with a CAGR of 10.68% from 2026-2035. Another report indicated the U.S. market was estimated at USD 2.17 billion in 2024 and is projected to reach approximately USD 4.06 billion by 2030.
The **global Healthcare Learning Management Systems (LMS) market** was valued at USD 2.5 billion in 2024 and is projected to reach USD 6.19 billion by 2035, at a CAGR of 8.60% between 2025 and 2035. Another source valued the global Healthcare LMS market at USD 3.84 billion in 2023, projecting it to hit USD 8.35 billion by 2032 with a CAGR of 9%.
The **U.S. healthcare e-learning services market** (a related component) was valued at USD 4.41 billion in 2024 and is expected to reach USD 12.96 billion by 2032, growing at a CAGR of 14.51%.

Provider Solutions Segment

HealthStream's Provider Solutions segment, which includes platforms for medical staff credentialing, enrollment, and privileging processes, addresses the medical credentialing software and services market.

The **global credentialing software and services in healthcare market** is expected to reach USD 1.42 billion by 2030, with a CAGR of 8.3% from 2024 to 2030.
The **global medical credentialing services market** is projected to grow from USD 6.85 billion in 2024 to USD 13.25 billion by 2032, with a CAGR of 8.6%. Another estimate valued the global medical credentialing services market at USD 6.8 billion in 2023, expecting it to reach USD 14.9 billion by 2032.
The **U.S. credentialing software and services in healthcare market** was valued at USD 268.35 billion in 2024 and is projected to reach approximately USD 526.41 billion by 2034, growing at a CAGR of 6.97% from 2025 to 2034.

```

AI Analysis | Feedback

HealthStream (HSTM) is expected to drive future revenue growth over the next 2-3 years through several key strategies:

Growth and Expanded Adoption of Core SaaS Solutions: HealthStream anticipates continued robust growth from its flagship subscription-based products, particularly CredentialStream and ShiftWizard. CredentialStream, a leading credentialing solution, has demonstrated significant revenue increases, including 21% in Q4 2025 and 28% in Q4 2024, by automating and streamlining critical administrative tasks for healthcare organizations. Similarly, ShiftWizard, a scheduling application, saw revenue growth of 31% in Q4 2025 and 17% in Q4 2024. These products are central to the company's subscription revenue, which constituted 96% of total revenues in Q4 2025 and grew by 8.2% year-over-year.
Strategic Integration and Monetization of the hStream Platform: The company is consolidating its offerings onto the hStream platform, transforming it into an integrated ecosystem for workforce solutions that unifies credentialing, scheduling, learning, and analytics. This platform incorporates AI as a core element to enhance interoperability and make SaaS applications behave more cohesively. This strategic shift is intended to drive higher recurring revenue and expand operating margins by improving customer lifetime value and reducing legacy support costs.
Targeted Strategic Acquisitions: HealthStream has a history of growth through acquiring complementary businesses and plans for this to continue. Recent acquisitions, such as Virsys12 and MissionCare Collective in late 2025, are aimed at enhancing service capabilities and competitive positioning. Historically, the company built its leading CredentialStream solution through a series of strategic acquisitions like Sy.Med, Healthline Systems, Morrisey Associates, and CredentialMyDoc.
Expansion into New Customer Segments and Deeper Market Penetration: HealthStream is actively seeking to expand its market reach by targeting new segments, such as the health plan market with its "Network by HealthStream" product, which secured 10 new accounts in Q2 2024. The company also aims for deeper penetration into existing markets, including post-acute care, and intends to leverage predictive workforce analytics to boost subscriber lifetime value. Additionally, HealthStream is exploring new revenue streams by partnering with device and pharmaceutical manufacturers to host product training on its platform.

AI Analysis | Feedback

Capital Allocation Decisions for HealthStream (HSTM) over the Last 3-5 Years

Share Repurchases

  On March 13, 2026, HealthStream's Board of Directors approved a new share repurchase program, authorizing the repurchase of up to $10,000,000 of its outstanding common stock, with the program set to terminate by September 12, 2026, or when the authorized amount is fully expended.
  In November 2025, HealthStream authorized a $10 million share repurchase program, of which $5 million was repurchased in the fourth quarter of 2025 and the remaining $5 million in January 2026.
  The company completed a $25 million share repurchase program that was authorized on May 8, 2025, and concluded in July 2025.


Share Issuance

  In December 2025, HealthStream's CEO contributed $3.8 million of his personally owned stock to the company, facilitating the grant of 146,286 shares to over 700 non-officer employees under the 2022 Omnibus Incentive Plan, resulting in a $3.8 million charge for stock-based compensation.


Outbound Investments

  In the fourth quarter of 2025, HealthStream completed two strategic acquisitions: Virsys12 for $13.0 million in cash (plus up to $4.0 million contingent) and MissionCare Collective for $40 million.
  During 2024, HealthStream acquired TCPS for $1.65 million and The Clinical Hub for $600K.
  In 2023, HealthStream acquired Eeds for $7 million.


Capital Expenditures

  HealthStream's capital expenditures incurred during 2025 totaled $31.9 million, or $32.2 million, representing a 14.3% increase year-over-year.
  For the upcoming year, 2026, capital expenditures are projected to be between $31 million and $34 million.
  A significant portion of the company's capital expenditures is historically allocated to capitalized software development, with recent investments focusing on its single platform strategy and scheduling application suite.



	
		
			
				
					
					 Interactive Breakdown
null

null
				
			
		
	

	
		
			
				
				 Better Bets vs. HealthStream (HSTM)
				
					By Industry
					By Sector
					All Other Sectors
					Sector Best Bets
				
				
					
				
					
						INDUSTRY: Health Care Technology
					
			
					
						
							Higher Rev Chg 3Y Avg | Lower P/S 
							(Values for HSTM: 4.9% | 2.2x)
						
						
				
						
							CERT (6.8% | 2.0x)
							Certara
						
					
						
							PHR (19.7% | 1.1x)
							Phreesia
						
					
						
							WEAV (18.8% | 1.8x)
							Weave Communications
						
					
						
							EVH (11.9% | 0.2x)
							Evolent Health
						
					
						
							LFMD (14.3% | 1.1x)
							LifeMD
						
					
					
						
							Higher Rev Chg 3Y Avg | Lower P/Op Inc 
							(Values for HSTM: 4.9% | 29.9x)
						
						
				
						
							VEEV (14.1% | 28.6x)
							Veeva Systems
						
					
						
							DOCS (15.5% | 17.2x)
							Doximity
						
					
						
							OPRX (20.4% | 6.4x)
							OptimizeRx
						
					
					
						
							Higher Rev Chg LTM 
							(Value for HSTM: 6.6%)
						
						
				
						
							TEM (69.8%)
							Tempus AI
						
					
						
							HNGE (49.8%)
							Hinge Health
						
					
						
							WAY (18.6%)
							Waystar
						
					
						
							VEEV (16.3%)
							Veeva Systems
						
					
						
							DOCS (13.1%)
							Doximity
						
					
					
						
							Higher Rev Chg 3Y Avg 
							(Value for HSTM: 4.9%)
						
						
				
						
							TEM (59.0%)
							Tempus AI
						
					
						
							OMDA (43.8%)
							Omada Health
						
					
						
							DOCS (15.5%)
							Doximity
						
					
						
							VEEV (14.1%)
							Veeva Systems
						
					
						
							TXG (6.3%)
							10x Genomics
						
					
					
						
							Higher Op Mgn LTM 
							(Value for HSTM: 7.5%)
						
						
				
						
							DOCS (33.3%)
							Doximity
						
					
						
							VEEV (28.7%)
							Veeva Systems
						
					
						
							WAY (22.9%)
							Waystar
						
					
						
							NRC (14.1%)
							NRC Health
						
					
						
							GDRX (9.9%)
							GoodRx
						
					
					
						
							Higher CFO/Rev LTM 
							(Value for HSTM: 20.3%)
						
						
				
						
							DOCS (50.6%)
							Doximity
						
					
						
							VEEV (44.3%)
							Veeva Systems
						
					
						
							HNGE (32.4%)
							Hinge Health
						
					
						
							WAY (28.6%)
							Waystar
						
					
						
							GDRX (21.6%)
							GoodRx
						
					
					
						
							Higher FCF/Rev LTM 
							(Value for HSTM: 10.5%)
						
						
				
						
							DOCS (49.2%)
							Doximity
						
					
						
							VEEV (44.3%)
							Veeva Systems
						
					
						
							HNGE (31.4%)
							Hinge Health
						
					
						
							WAY (25.4%)
							Waystar
						
					
						
							TXG (19.1%)
							10x Genomics
						
					
					
						
							Higher Total Yield 
							(Value for HSTM: 3.4%)
						
						
				
						
							SPOK (17.5%)
							Spok
						
					
						
							SOLV (10.7%)
							Solventum
						
					
						
							DOCS (5.3%)
							Doximity
						
					
						
							NRC (5.0%)
							NRC Health
						
					
						
							VEEV (3.5%)
							Veeva Systems
						
					
					
				
					
						SECTOR: Health Care
					
			
					
						
							Higher Rev Chg 3Y Avg | Lower P/S 
							(Values for HSTM: 4.9% | 2.2x)
						
						
				
						
							UNH (10.2% | 0.8x)
							UnitedHealth
						
					
						
							CVS (7.2% | 0.3x)
							CVS Health
						
					
						
							MCK (13.4% | 0.2x)
							McKesson
						
					
						
							HCA (7.9% | 1.2x)
							HCA Healthcare
						
					
						
							ELV (7.7% | 0.4x)
							Elevance Health
						
					
					
						
							Higher Rev Chg 3Y Avg | Lower P/Op Inc 
							(Values for HSTM: 4.9% | 29.9x)
						
						
				
						
							LLY (37.9% | 27.9x)
							Eli Lilly
						
					
						
							UNH (10.2% | 18.7x)
							UnitedHealth
						
					
						
							AMGN (12.5% | 17.3x)
							Amgen
						
					
						
							SYK (10.1% | 23.7x)
							Stryker
						
					
						
							CVS (7.2% | 10.2x)
							CVS Health
						
					
					
						
							Higher Rev Chg LTM 
							(Value for HSTM: 6.6%)
						
						
				
						
							LLY (47.4%)
							Eli Lilly
						
					
						
							UNH (9.7%)
							UnitedHealth
						
					
						
							ABBV (9.5%)
							AbbVie
						
					
						
							AMGN (9.1%)
							Amgen
						
					
						
							JNJ (7.9%)
							Johnson & Johnson
						
					
					
						
							Higher Rev Chg 3Y Avg 
							(Value for HSTM: 4.9%)
						
						
				
						
							LLY (37.9%)
							Eli Lilly
						
					
						
							ISRG (18.1%)
							Intuitive Surgical
						
					
						
							AMGN (12.5%)
							Amgen
						
					
						
							UNH (10.2%)
							UnitedHealth
						
					
						
							SYK (10.1%)
							Stryker
						
					
					
						
							Higher Op Mgn LTM 
							(Value for HSTM: 7.5%)
						
						
				
						
							LLY (47.3%)
							Eli Lilly
						
					
						
							ABBV (33.2%)
							AbbVie
						
					
						
							AMGN (28.4%)
							Amgen
						
					
						
							JNJ (26.8%)
							Johnson & Johnson
						
					
						
							MRK (19.7%)
							Merck
						
					
					
						
							Higher CFO/Rev LTM 
							(Value for HSTM: 20.3%)
						
						
				
						
							ABBV (33.8%)
							AbbVie
						
					
						
							AMGN (28.9%)
							Amgen
						
					
						
							LLY (28.3%)
							Eli Lilly
						
					
						
							MRK (27.2%)
							Merck
						
					
						
							JNJ (23.7%)
							Johnson & Johnson
						
					
					
						
							Higher FCF/Rev LTM 
							(Value for HSTM: 10.5%)
						
						
				
						
							ABBV (31.8%)
							AbbVie
						
					
						
							AMGN (23.1%)
							Amgen
						
					
						
							MRK (21.5%)
							Merck
						
					
						
							JNJ (18.1%)
							Johnson & Johnson
						
					
						
							LLY (14.4%)
							Eli Lilly
						
					
					
						
							Higher Total Yield 
							(Value for HSTM: 3.4%)
						
						
				
						
							AMGN (7.1%)
							Amgen
						
					
						
							JNJ (5.9%)
							Johnson & Johnson
						
					
						
							UNH (5.7%)
							UnitedHealth
						
					
						
							MRK (5.7%)
							Merck
						
					
						
							ABBV (4.0%)
							AbbVie
						
					
					
				
					
						All Other Sectors
					
			
					
						
							Higher Rev Chg 3Y Avg | Lower P/S 
							(Values for HSTM: 4.9% | 2.2x)
						
						
				
						
							WMT (5.3% | 1.3x)
							Walmart
						
					
						
							COST (6.9% | 1.6x)
							Costco Wholesale
						
					
						
							BA (10.7% | 1.9x)
							Boeing
						
					
						
							CB (11.3% | 2.1x)
							Chubb
						
					
						
							ENB (13.7% | 1.8x)
							Enbridge
						
					
					
						
							Higher Rev Chg 3Y Avg | Lower P/Op Inc 
							(Values for HSTM: 4.9% | 29.9x)
						
						
				
						
							MSFT (15.3% | 20.9x)
							Microsoft
						
					
						
							META (22.4% | 17.5x)
							Meta Platforms
						
					
						
							V (11.6% | 20.6x)
							Visa
						
					
						
							ORCL (10.2% | 26.7x)
							Oracle
						
					
						
							MA (14.2% | 22.0x)
							Mastercard
						
					
					
						
							Higher Rev Chg LTM 
							(Value for HSTM: 6.6%)
						
						
				
						
							NVDA (70.7%)
							NVIDIA
						
					
						
							MSFT (17.9%)
							Microsoft
						
					
						
							GOOGL (17.5%)
							Alphabet
						
					
						
							AMZN (14.2%)
							Amazon.com
						
					
						
							AAPL (12.8%)
							Apple
						
					
					
						
							Higher Rev Chg 3Y Avg 
							(Value for HSTM: 4.9%)
						
						
				
						
							NVDA (121.7%)
							NVIDIA
						
					
						
							MSFT (15.3%)
							Microsoft
						
					
						
							GOOGL (14.1%)
							Alphabet
						
					
						
							AMZN (12.3%)
							Amazon.com
						
					
						
							AAPL (5.6%)
							Apple
						
					
					
						
							Higher Op Mgn LTM 
							(Value for HSTM: 7.5%)
						
						
				
						
							NVDA (64.0%)
							NVIDIA
						
					
						
							MSFT (46.8%)
							Microsoft
						
					
						
							GOOGL (32.7%)
							Alphabet
						
					
						
							AAPL (32.6%)
							Apple
						
					
						
							AMZN (11.5%)
							Amazon.com
						
					
					
						
							Higher CFO/Rev LTM 
							(Value for HSTM: 20.3%)
						
						
				
						
							MSFT (53.5%)
							Microsoft
						
					
						
							NVDA (49.6%)
							NVIDIA
						
					
						
							AVGO (43.5%)
							Broadcom
						
					
						
							GOOGL (41.3%)
							Alphabet
						
					
						
							AAPL (31.1%)
							Apple
						
					
					
						
							Higher FCF/Rev LTM 
							(Value for HSTM: 10.5%)
						
						
				
						
							NVDA (47.0%)
							NVIDIA
						
					
						
							AVGO (42.3%)
							Broadcom
						
					
						
							AAPL (28.6%)
							Apple
						
					
						
							MSFT (22.9%)
							Microsoft
						
					
						
							GOOGL (15.2%)
							Alphabet
						
					
					
						
							Higher Total Yield 
							(Value for HSTM: 3.4%)
						
						
				
						
							JPM (7.1%)
							JPMorgan Chase
						
					
						
							BRK-B (6.9%)
							Berkshire Hathaway
						
					
						
							META (4.9%)
							Meta Platforms
						
					
						
							MSFT (4.9%)
							Microsoft
						
					
						
							GOOGL (3.7%)
							Alphabet
						
					
					
				
					
						Best Bets in Health Care
					
			What You Pay
					
						
							P/EBIT 
							(Value for HSTM: 29.9x)
						
						
				
						
							RPRX (14.0x)
							Royalty Pharma
						
					
						
							DOCS (17.2x)
							Doximity
						
					
						
							VEEV (28.6x)
							Veeva Systems
						
					
						
							HALO (15.4x)
							Halozyme Therapeutics
						
					
						
							CPRX (14.3x)
							Catalyst Pharmaceuticals
						
					
						
							GILD (14.2x)
							Gilead Sciences
						
					
						
							RMD (15.8x)
							ResMed
						
					
						
							EXEL (13.5x)
							Exelixis
						
					
						
							BMY (10.6x)
							Bristol-Myers Squibb
						
					
						
							NBIX (19.7x)
							Neurocrine Biosciences
						
					
					
						
							P/E 
							(Value for HSTM: 35.1x)
						
						
				
						
							RPRX (28.8x)
							Royalty Pharma
						
					
						
							DOCS (18.8x)
							Doximity
						
					
						
							VEEV (28.8x)
							Veeva Systems
						
					
						
							HALO (23.1x)
							Halozyme Therapeutics
						
					
						
							CPRX (17.3x)
							Catalyst Pharmaceuticals
						
					
						
							GILD (18.1x)
							Gilead Sciences
						
					
						
							RMD (19.9x)
							ResMed
						
					
						
							EXEL (15.5x)
							Exelixis
						
					
						
							BMY (16.7x)
							Bristol-Myers Squibb
						
					
						
							NBIX (23.6x)
							Neurocrine Biosciences
						
					
What You Get
					
						
							Rev Chg 3Y Avg 
							(Value for HSTM: 4.9%)
						
						
				
						
							RPRX (1.3%)
							Royalty Pharma
						
					
						
							DOCS (15.5%)
							Doximity
						
					
						
							VEEV (14.1%)
							Veeva Systems
						
					
						
							HALO (29.1%)
							Halozyme Therapeutics
						
					
						
							CPRX (34.0%)
							Catalyst Pharmaceuticals
						
					
						
							GILD (3.2%)
							Gilead Sciences
						
					
						
							RMD (11.3%)
							ResMed
						
					
						
							EXEL (12.9%)
							Exelixis
						
					
						
							BMY (1.9%)
							Bristol-Myers Squibb
						
					
						
							NBIX (24.8%)
							Neurocrine Biosciences
						
					
					
						
							Rev Chg LTM 
							(Value for HSTM: 6.6%)
						
						
				
						
							RPRX (7.8%)
							Royalty Pharma
						
					
						
							DOCS (13.1%)
							Doximity
						
					
						
							VEEV (16.3%)
							Veeva Systems
						
					
						
							HALO (39.1%)
							Halozyme Therapeutics
						
					
						
							CPRX (11.7%)
							Catalyst Pharmaceuticals
						
					
						
							GILD (3.5%)
							Gilead Sciences
						
					
						
							RMD (10.3%)
							ResMed
						
					
						
							EXEL (3.3%)
							Exelixis
						
					
						
							BMY (1.8%)
							Bristol-Myers Squibb
						
					
						
							NBIX (28.6%)
							Neurocrine Biosciences
						
					
					
						
							Rev Chg Q 
							(Value for HSTM: 10.5%)
						
						
				
						
							RPRX (11.0%)
							Royalty Pharma
						
					
						
							DOCS (5.1%)
							Doximity
						
					
						
							VEEV (16.0%)
							Veeva Systems
						
					
						
							HALO (42.2%)
							Halozyme Therapeutics
						
					
						
							CPRX (5.6%)
							Catalyst Pharmaceuticals
						
					
						
							GILD (4.4%)
							Gilead Sciences
						
					
						
							RMD (10.8%)
							ResMed
						
					
						
							EXEL (10.0%)
							Exelixis
						
					
						
							BMY (2.6%)
							Bristol-Myers Squibb
						
					
						
							NBIX (42.2%)
							Neurocrine Biosciences
						
					
					
						
							FCF/Rev 3Y Avg 
							(Value for HSTM: 11.8%)
						
						
				
						
							RPRX (114.4%)
							Royalty Pharma
						
					
						
							DOCS (44.5%)
							Doximity
						
					
						
							VEEV (40.8%)
							Veeva Systems
						
					
						
							HALO (39.9%)
							Halozyme Therapeutics
						
					
						
							CPRX (34.9%)
							Catalyst Pharmaceuticals
						
					
						
							GILD (32.5%)
							Gilead Sciences
						
					
						
							RMD (28.6%)
							ResMed
						
					
						
							EXEL (27.2%)
							Exelixis
						
					
						
							BMY (26.5%)
							Bristol-Myers Squibb
						
					
						
							NBIX (26.0%)
							Neurocrine Biosciences
						
					
			
				[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 11%, alpha of 1.9%, and sharpe of 0.52
			
		
				
			
		
	

	
		
			
				
				 Latest Trefis Analyses
				 Title Date
0 DASHBOARDS  
1 HealthStream Earnings Notes 12/16/2025
2 How Low Can HealthStream Stock Really Go? 10/17/2025
3 HealthStream (HSTM) Operating Cash Flow Comparison 02/17/2025
4 HealthStream (HSTM) Net Income Comparison 02/15/2025
5 HealthStream (HSTM) Operating Income Comparison 02/15/2025
6 HealthStream (HSTM) Revenue Comparison 02/13/2025
 Title
0 ARTICLES
			
		
	

	
		
			
				
				 Trade Ideas
Select ideas related to HSTM.
Unique Key Date Ticker Company Category Trade Strategy 6M Fwd Rtn 12M Fwd Rtn 12M Max DD
GEHC_4302026_Dip_Buyer_FCFYield 04302026 GEHC GE HealthCare Technologies Dip Buy DB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin 0.0% 0.0% 0.0%
IQV_4302026_Dip_Buyer_FCFYield 04302026 IQV IQVIA Dip Buy DB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin 0.0% 0.0% 0.0%
UHS_4302026_Dip_Buyer_FCFYield 04302026 UHS Universal Health Services Dip Buy DB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin 0.0% 0.0% 0.0%
ABT_4302026_Dip_Buyer_ValueBuy 04302026 ABT Abbott Laboratories Dip Buy DB | P/E OPMDip Buy with Low PE and High Margin
Buying dips for companies with tame PE and meaningfully high operating margin 0.0% 0.0% 0.0%
ZBIO_4302026_Insider_Buying_45D_2Buy_200K 04302026 ZBIO Zenas BioPharma Insider Insider Buys 45DStrong Insider Buying
Companies with multiple insider buys in the last 45 days 0.0% 0.0% 0.0%
			
		
	

	
		
			
				
				 Recent Active Movers
				
					1D
					1W
					1M
				
				
					Top Gainers
Ticker Company Mkt Cap (B) 1D Rtn YTD Rtn
NVTS Navitas Semiconductor 6.5 20.0% 309.7%
RGTI Rigetti Computing 8.7 19.9% 19.3%
HLIT Harmonic 1.7 19.7% 53.7%
BB BlackBerry 4.7 18.9% 108.7%
LPTH LightPath Technologies 0.8 18.7% 56.9%
SHAZ SharonAI 0.8 18.0% -26.4%
AEVA Aeva Technologies 1.5 17.8% 90.7%
DELL Dell Technologies 194.8 16.8% 135.5%
AXTI AXT 6.3 16.4% 761.3%
LION Lionsgate Studios 4.3 15.8% 63.7%
Top Losers
Ticker Company Mkt Cap (B) 1D Rtn YTD Rtn
GKOS Glaukos 6.9 -13.5% 6.5%
FBYD Falcons Beyond Global 0.7 -13.3% 10.3%
BTGO BitGo 0.8 -10.7% -62.5%
IHRT iHeartMedia 0.7 -9.6% 6.0%
HOV Hovnanian Enterprises 0.7 -8.9% 7.9%
INBX Inhibrx Biosciences 1.6 -8.4% 28.3%
BJ BJ's Wholesale Club 11.3 -8.2% -3.8%
OPTU Optimum Communications 0.3 -7.4% -59.9%
TE T1 Energy 1.8 -7.3% 21.0%
ETON Eton Pharmaceuticals 0.9 -6.9% 92.7%
					Top Gainers
Ticker Company Mkt Cap (B) 1W Rtn YTD Rtn
FBYD Falcons Beyond Global 0.7 57.0% 10.3%
HIVE HIVE Digital Technologies 1.0 51.3% 57.8%
RGTI Rigetti Computing 8.7 48.0% 19.3%
LPTH LightPath Technologies 0.8 47.1% 56.9%
QBTS D-Wave Quantum 10.4 44.5% 12.4%
TE T1 Energy 1.8 42.5% 21.0%
NVTS Navitas Semiconductor 6.5 37.2% 309.7%
PSNL Personalis 0.8 33.2% 6.4%
ALAB Astera Labs 52.0 31.9% 84.5%
RXO RXO 4.1 30.4% 92.8%
Top Losers
Ticker Company Mkt Cap (B) 1W Rtn YTD Rtn
DSGN Design Therapeutics 0.6 -23.7% 17.0%
BTGO BitGo 0.8 -22.0% -62.5%
FIGR Figure Technology Solutions 7.3 -21.6% -16.9%
GTN-A Gray Media 0.8 -20.4% -29.8%
INTU Intuit 88.9 -18.6% -51.5%
OPTU Optimum Communications 0.3 -17.8% -59.9%
EIKN Eikon Therapeutics 0.6 -17.7% -27.3%
GKOS Glaukos 6.9 -16.5% 6.5%
ONDS Ondas 3.4 -14.7% -7.2%
STRL Sterling Infrastructure 22.5 -13.7% 139.3%
					Top Gainers
Ticker Company Mkt Cap (B) 1M Rtn YTD Rtn
MXL MaxLinear 8.7 189.5% 468.9%
BAND Bandwidth 1.9 167.5% 297.3%
WOLF Wolfspeed 1.9 153.7% 301.4%
INOD Innodata 3.1 119.6% 87.4%
FCEL FuelCell Energy 1.2 105.5% 242.1%
VPG Vishay Precision 1.5 96.9% 195.5%
PENG Penguin Solutions 2.8 92.7% 172.0%
XMTR Xometry 4.6 90.3% 50.0%
AXTI AXT 6.3 87.1% 761.3%
INTC Intel 609.1 79.5% 224.8%
Top Losers
Ticker Company Mkt Cap (B) 1M Rtn YTD Rtn
EMBC Embecta 0.2 -63.7% -71.6%
FWRD Forward Air 0.3 -61.3% -64.8%
OPTU Optimum Communications 0.3 -60.4% -59.9%
CABO Cable One 0.3 -54.5% -53.7%
PSIX Power Solutions International 0.9 -50.3% -32.0%
ERAS Erasca 3.2 -50.0% 202.2%
TRDA Entrada Therapeutics 0.3 -48.8% -36.2%
BRBR BellRing Brands 1.1 -45.3% -66.7%
ULH Universal Logistics 0.4 -42.8% -6.0%
UI Ubiquiti 37.0 -41.1% 10.6%
				
			
		
	

	
		 More From Trefis
		
			
				Research & Analysis
				
					Latest Ideas
					Dip Buying Opportunities
					Earnings Reaction Data
				
			
		
		
			
				Invest in Strategies
				
					Invest in Trefis Strategies
					Advisor Strategies & Resources
				
			
		
		
			
				Wealth Management
				
					Help Me Invest
					Rules-Based Wealth Management
				
			
		
	

	
		
			
				 Peer Comparisons
Peers to compare with: 
				
				Financials
 HSTM WDAY ORCL NOW ADP PAYX Median
Name HealthSt. Workday  Oracle   ServiceN. Automati. Paychex   
Mkt Price 23.81 128.14 192.08 102.13 225.31 97.00 115.13
Mkt Cap 0.7 32.5 552.0 105.7 90.5 34.8 62.7
Rev LTM 312 9,854 64,077 13,960 21,600 6,334 11,907
Op Inc LTM 23 1,156 20,678 1,876 5,727 2,337 2,106
FCF LTM 33 2,972 -24,736 4,624 4,841 2,090 2,531
FCF 3Y Avg 35 2,427 -2,222 3,800 4,190 1,875 2,151
CFO LTM 63 3,178 23,514 5,437 5,452 2,320 4,308
CFO 3Y Avg 64 2,656 20,833 4,626 4,765 2,064 3,641
				Growth & Margins
 HSTM WDAY ORCL NOW ADP PAYX Median
Name HealthSt. Workday  Oracle   ServiceN. Automati. Paychex   
Rev Chg LTM 6.6% 13.3% 14.9% 21.7% 6.9% 16.4% 14.1%
Rev Chg 3Y Avg 4.9% 15.1% 10.2% 22.4% 6.9% 8.9% 9.5%
Rev Chg Q 10.5% 13.5% 21.7% 22.1% 7.0% 19.9% 16.7%
QoQ Delta Rev Chg LTM 2.5% 3.2% 5.0% 5.1% 1.8% 5.0% 4.1%
Op Inc Chg LTM 17.0% 82.9% 16.6% 26.5% 7.9% 3.5% 16.8%
Op Inc Chg 3Y Avg 29.9% 175.2% 13.7% 71.1% 10.0% 5.8% 21.8%
Op Mgn LTM 7.5% 11.7% 32.3% 13.4% 26.5% 36.9% 20.0%
Op Mgn 3Y Avg 7.0% 7.5% 31.2% 12.1% 26.2% 39.9% 19.2%
QoQ Delta Op Mgn LTM 0.8% 1.0% 0.3% -0.3% 0.2% -0.2% 0.3%
CFO/Rev LTM 20.3% 32.3% 36.7% 38.9% 25.2% 36.6% 34.4%
CFO/Rev 3Y Avg 21.6% 30.4% 36.2% 39.9% 23.5% 36.5% 33.3%
FCF/Rev LTM 10.5% 30.2% -38.6% 33.1% 22.4% 33.0% 26.3%
FCF/Rev 3Y Avg 11.8% 27.7% -1.6% 32.7% 20.6% 33.2% 24.2%
				Valuation
 HSTM WDAY ORCL NOW ADP PAYX Median
Name HealthSt. Workday  Oracle   ServiceN. Automati. Paychex   
Mkt Cap 0.7 32.5 552.0 105.7 90.5 34.8 62.7
P/S 2.2 3.3 8.6 7.6 4.2 5.5 4.8
P/Op Inc 29.9 28.1 26.7 56.4 15.8 14.9 27.4
P/EBIT 29.9 23.7 24.6 44.0 14.8 14.4 24.1
P/E 35.1 38.4 34.1 60.2 20.8 21.3 34.6
P/CFO 11.0 10.2 23.5 19.4 16.6 15.0 15.8
Total Yield 3.4% 2.6% 4.0% 1.7% 7.6% 9.2% 3.7%
Dividend Yield 0.5% 0.0% 1.0% 0.0% 2.8% 4.5% 0.8%
FCF Yield 3Y Avg 4.5% 5.2% 0.4% 2.8% 4.2% 4.5% 4.4%
D/E 0.0 0.1 0.3 0.0 0.0 0.1 0.1
Net D/E -0.1 -0.0 0.2 -0.0 0.0 0.1 -0.0
				Returns
 HSTM WDAY ORCL NOW ADP PAYX Median
Name HealthSt. Workday  Oracle   ServiceN. Automati. Paychex   
1M Rtn 11.0% 1.2% 2.4% -0.9% 11.7% 5.2% 3.8%
3M Rtn 17.4% -7.0% 30.2% -2.1% 5.9% 7.7% 6.8%
6M Rtn -6.2% -43.1% -2.8% -37.2% -9.7% -10.9% -10.3%
12M Rtn -13.9% -52.9% 23.3% -49.7% -28.2% -35.3% -31.8%
3Y Rtn 0.1% -33.6% 101.9% 2.1% 12.0% -1.6% 1.1%
1M Excs Rtn 9.0% 6.6% 3.8% 15.3% 8.4% 2.9% 7.5%
3M Excs Rtn 3.2% -10.1% 27.1% -8.0% 1.1% 3.1% 2.1%
6M Excs Rtn -15.5% -55.3% -26.8% -50.0% -21.2% -21.9% -24.4%
12M Excs Rtn -43.1% -80.2% -4.4% -77.5% -56.3% -63.2% -59.8%
3Y Excs Rtn -78.0% -111.6% 19.7% -76.1% -66.9% -79.9% -77.1%
				Comparison Analyses
null
			
		
	

	
		
			
				
				 FDIC Bank Data
				Capital & Deposits
Assets
Loans
				
					Bank Capital
nullBank Deposits
null
					Bank Assets
null
					Bank Loans
null
				
			
		
	

	
		
			
				
				 FDA Approved Drugs Data
				Expand for Morenull
				Collapse to Previewnull
			
		
	

	
		
			
				
				 Financials
				Annual
Quarterly
				$ Mil | FY: 12/31 LTM 2025 2024 2023 2022 2021 2020
Period End 3/31/2026 12/31/2025 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020
Filing Date 5/6/2026 2/27/2026 2/28/2025 2/26/2024 2/28/2023 2/28/2022 2/26/2021

Key Financials              
Total Revenue 312 304 292 279 267 257 245
EBITDA 67 64 63 57 50 45 46
Operating Income 23 20 21 16 12 8 16
Net Income 20 18 20 15 12 6 14
EPS 0.67 0.61 0.66 0.50 0.39 0.19 0.44

Growth Rates              
Total Revenue Growth 6.6% 4.3% 4.5% 4.6% 3.9% 4.9% -3.7%
EBITDA Growth 9.4% 1.9% 9.5% 13.3% 12.3% -2.5% 8.0%
Operating Income Growth 17.0% -4.9% 32.9% 28.7% 54.5% -49.1% 7.5%
Net Income Growth 4.2% -8.3% 31.5% 25.8% 106.9% -58.5% -10.6%

Margins              
EBITDA Margin 21.6% 21.0% 21.4% 20.5% 18.9% 17.5% 18.8%
Operating Income Margin 7.5% 6.7% 7.3% 5.7% 4.7% 3.1% 6.5%
Net Income Margin 6.4% 6.0% 6.9% 5.5% 4.5% 2.3% 5.8%

Cash & Debt              
Total Cash 66 57 97 71 54 52 46
Total Debt 14 15 17 20 23 26 28
Net Debt / (Cash) -52 -42 -80 -51 -31 -26 -18

Cash Flows              
Net Cash from Operations 63 63 58 64 51 42 36
Free Cash from Operations 33 31 30 36 26 17 17

Returns to Shareholders              
Dividends 4 4 3 3 -0 0 0
Share Repurchases 37 30 -0 9 23 5 20
$ Mil | FY: 12/31 2026Q1 2025Q4 2025Q3 2025Q2 2025Q1 2024Q4 2024Q3 2024Q2 2024Q1 2023Q4 2023Q3 2023Q2
Period End 3/31/2026 12/31/2025 9/30/2025 6/30/2025 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023
Filing Date 5/6/2026 2/27/2026 11/6/2025 8/7/2025 5/9/2025 2/28/2025 10/24/2024 7/25/2024 4/25/2024 2/26/2024 10/26/2023 7/27/2023

Key Financials Quarterly                        
Total Revenue 81 80 76 74 73 74 73 72 73 71 70 69
Ebitda 19 13 18 17 15 15 17 15 16 15 15 14
Operating Income 8 2 8 6 4 5 6 4 6 4 5 4
Net Income 6 3 6 5 4 5 6 4 5 5 4 4
EPS 0.20 0.09 0.20 0.18 0.14 0.16 0.19 0.14 0.17 0.15 0.13 0.13

Key Financials TTM                        
Total Revenue TTM 312 304 299 295 292 292 288 285 283 279 277 274
Ebitda TTM 67 64 65 64 62 63 62 61 60 57 55 52
Operating Income TTM 23 20 23 21 20 21 21 19 19 16 15 12
Net Income TTM 20 18 21 20 19 20 20 18 18 15 13 13

Growth Rates Quarterly                        
Total Revenue Growth 10.5% 7.4% 4.6% 4.0% 1.0% 5.2% 3.9% 3.4% 5.5% 3.0% 4.5% 5.4%
EBITDA Growth 24.7% -11.3% 11.0% 13.3% -5.6% 2.5% 8.5% 3.9% 25.0% 16.5% 27.5% 15.0%
Operating Income Growth 71.6% -48.7% 16.5% 33.4% -23.1% 10.2% 33.6% 10.1% 96.8% 38.3% 104.2% 35.7%
Net Income Growth 36.4% -48.2% 6.3% 29.3% -17.1% 6.5% 48.0% 0.8% 99.3% 87.4% 5.5% 34.1%

Margins Quarterly                        
EBITDA Margin 23.2% 16.9% 24.0% 22.5% 20.6% 20.4% 22.7% 20.7% 22.0% 20.9% 21.7% 20.6%
Operating Income Margin 9.3% 3.0% 9.9% 7.9% 6.0% 6.3% 8.9% 6.2% 7.8% 6.0% 6.9% 5.8%
Net Income Margin 7.3% 3.2% 8.0% 7.2% 5.9% 6.6% 7.8% 5.8% 7.2% 6.5% 5.5% 6.0%

Cash & Debt                        
Total Cash 66 57 93 91 113 97 95 83 84 71 72 56
Total Debt 14 15 15 16 17 17 18 19 19 20 21 22
Net Debt / (Cash) -52 -42 -77 -75 -97 -80 -77 -64 -64 -51 -51 -34

Cash Flows Quarterly                        
FCF from Operations 27 13 18 5 27 11 19 6 21 14 25 5

Cash Flows TTM                        
FCF from Operations TTM 63 63 61 62 64 58 60 66 64 64 58 49

Returns to Shareholders Quarterly                        
Dividends 1 1 1 1 1 1 1 1 1 1 1 2
Share Repurchases 7 5 7 18 -0 -0 -0 -0 -0 7 2 -0

Return on Invested Capital (ROIC) Quarterly                        
ROIC 13.3% 4.5% 14.9% 11.6% 9.4% 9.8% 11.5% 7.5% 9.9% 7.3% 6.8% 6.7%

Return on Invested Capital (ROIC) TTM                        
ROIC TTM 10.5% 8.5% 12.0% 10.9% 10.6% 10.1% 9.6% 8.2% 8.3% 6.7% 5.8% 4.5%
			
		
	

	
		
			
				
				 Segment Financials
Revenue by Segment
$ Mil 2025 2024 2023 2022 2021
Subscription services 280 268 254    
Professional services 11 11 13    
Total 292 279 267    



			
		
	

	
		
			
				
				 Price Behavior
				Behavior Stats
Betas Matrix
Behavior vs Other Asset Classes
				
					Price Behavior
Market Price $23.81  
Market Cap ($ Bil) 0.7  
First Trading Date 04/11/2000  
Distance from 52W High -18.4%  
    50 Days 200 Days
DMA Price $21.59 $23.82
DMA Trend down up
Distance from DMA 10.3% -0.1%
  3M 1YR
Volatility 44.0% 29.6%
Downside Capture 15.45 85.99
Upside Capture 69.60 42.45
Correlation (SPY) 4.8% 20.4%
					
HSTM Betas & Captures as of 4/30/2026


  1M 2M 3M 6M 1Y 3Y
Beta 0.08 0.37 0.31 0.38 0.67 0.56
Up Beta -0.69 -0.51 -0.50 -0.16 0.29 0.43
Down Beta -0.83 -1.05 -0.39 -0.23 0.43 0.42
Up Capture 43% 97% 71% 51% 38% 30%
Bmk +ve Days 15 22 31 66 141 428
Stock +ve Days 11 20 28 51 109 370
Down Capture 342% 119% 92% 99% 129% 94%
Bmk -ve Days 4 18 30 56 108 321
Stock -ve Days 11 23 35 73 139 373


[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
					
						
							1Y
							5Y
							10Y
						
						
							Based On 1-Year Data
 Annualized
Return Annualized
Volatility Sharpe
Ratio Correlation
with HSTM
HSTM -15.3% 29.6% -0.55 -
Sector ETF (XLV) 16.0% 14.5% 0.80 17.8%
Equity (SPY) 29.5% 12.0% 1.86 20.6%
Gold (GLD) 35.5% 26.8% 1.11 -6.4%
Commodities (DBC) 42.9% 18.7% 1.77 -7.1%
Real Estate (VNQ) 15.2% 13.1% 0.82 21.5%
Bitcoin (BTCUSD) -29.5% 41.7% -0.73 5.1%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
							Based On 5-Year Data
 Annualized
Return Annualized
Volatility Sharpe
Ratio Correlation
with HSTM
HSTM -1.3% 28.7% -0.02 -
Sector ETF (XLV) 5.7% 14.7% 0.21 32.7%
Equity (SPY) 14.0% 17.0% 0.64 32.4%
Gold (GLD) 18.8% 18.0% 0.85 -1.9%
Commodities (DBC) 10.4% 19.4% 0.42 0.7%
Real Estate (VNQ) 3.8% 18.8% 0.10 31.6%
Bitcoin (BTCUSD) 12.2% 55.3% 0.42 12.6%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
							Based On 10-Year Data
 Annualized
Return Annualized
Volatility Sharpe
Ratio Correlation
with HSTM
HSTM 1.3% 31.9% 0.11 -
Sector ETF (XLV) 9.9% 16.5% 0.49 36.0%
Equity (SPY) 15.7% 17.9% 0.75 37.1%
Gold (GLD) 13.0% 16.0% 0.67 -0.3%
Commodities (DBC) 7.8% 17.9% 0.35 9.6%
Real Estate (VNQ) 5.5% 20.7% 0.23 31.7%
Bitcoin (BTCUSD) 67.2% 66.9% 1.06 12.8%

Smart multi-asset allocation framework can stack odds in your favor. Learn How
						
					
				
			
		
		
			
				
				 Short Interest
Short Interest: As Of Date 4302026
Short Interest: Shares Quantity 1.0 Mil
Short Interest: % Change Since 4152026 7.9%
Average Daily Volume 0.2 Mil
Days-to-Cover Short Interest 6.1 days
Basic Shares Quantity 29.4 Mil
Short % of Basic Shares 3.4%
			
		
	

	
		
			
				 Returns Analyses
 Title
0 How Low Can HealthStream Stock Really Go?
			
		
	

	
		
			
				
				 Earnings Returns History
				Expand for More  Forward Returns
Earnings Date 1D Returns 5D Returns 21D Returns
5/4/2026 14.6% 8.8%  
2/23/2026 4.0% 0.6% -1.1%
11/3/2025 2.8% -3.1% -2.3%
8/4/2025 -1.2% -0.3% 7.8%
5/5/2025 -19.3% -17.4% -14.6%
2/24/2025 0.1% 3.4% -1.0%
10/21/2024 5.7% 1.8% 13.4%
7/22/2024 -4.0% -4.2% -7.7%
... 
SUMMARY STATS      
# Positive 12 10 6
# Negative 8 10 13
Median Positive 4.1% 3.4% 10.9%
Median Negative -5.8% -3.6% -3.5%
Max Positive 14.9% 14.1% 16.3%
Max Negative -19.3% -17.4% -14.6%
				Collapse to Preview  Forward Returns
Earnings Date 1D Returns 5D Returns 21D Returns
5/4/2026 14.6% 8.8%  
2/23/2026 4.0% 0.6% -1.1%
11/3/2025 2.8% -3.1% -2.3%
8/4/2025 -1.2% -0.3% 7.8%
5/5/2025 -19.3% -17.4% -14.6%
2/24/2025 0.1% 3.4% -1.0%
10/21/2024 5.7% 1.8% 13.4%
7/22/2024 -4.0% -4.2% -7.7%
2/20/2024 -1.6% -0.4% -3.5%
10/23/2023 14.9% 14.1% 16.3%
7/24/2023 -1.2% -2.9% -8.5%
2/21/2023 4.9% 3.4% 8.4%
10/24/2022 5.3% 13.5% 15.7%
7/25/2022 4.2% 3.7% -0.3%
2/22/2022 -17.0% -13.9% -13.3%
10/25/2021 -9.6% -5.2% -10.1%
7/26/2021 0.7% 0.5% 0.6%
2/22/2021 0.3% -0.3% -2.4%
10/26/2020 -7.6% -10.8% -7.6%
7/27/2020 1.8% 2.7% -2.2%
SUMMARY STATS      
# Positive 12 10 6
# Negative 8 10 13
Median Positive 4.1% 3.4% 10.9%
Median Negative -5.8% -3.6% -3.5%
Max Positive 14.9% 14.1% 16.3%
Max Negative -19.3% -17.4% -14.6%
			
		
		
			
				
				 SEC Filings
				Expand for MoreReport Date Filing Date Filing
03/31/2026 05/06/2026 10-Q
12/31/2025 02/27/2026 10-K
09/30/2025 11/06/2025 10-Q
06/30/2025 08/07/2025 10-Q
03/31/2025 05/09/2025 10-Q
12/31/2024 02/28/2025 10-K
09/30/2024 10/24/2024 10-Q
06/30/2024 07/25/2024 10-Q
03/31/2024 04/25/2024 10-Q
12/31/2023 02/26/2024 10-K
09/30/2023 10/26/2023 10-Q
06/30/2023 07/27/2023 10-Q
03/31/2023 04/27/2023 10-Q
12/31/2022 02/28/2023 10-K
09/30/2022 10/27/2022 10-Q
06/30/2022 07/28/2022 10-Q
				Collapse to PreviewReport Date Filing Date Filing
03/31/2026 05/06/2026 10-Q
12/31/2025 02/27/2026 10-K
09/30/2025 11/06/2025 10-Q
06/30/2025 08/07/2025 10-Q
03/31/2025 05/09/2025 10-Q
12/31/2024 02/28/2025 10-K
09/30/2024 10/24/2024 10-Q
06/30/2024 07/25/2024 10-Q
03/31/2024 04/25/2024 10-Q
12/31/2023 02/26/2024 10-K
09/30/2023 10/26/2023 10-Q
06/30/2023 07/27/2023 10-Q
03/31/2023 04/27/2023 10-Q
12/31/2022 02/28/2023 10-K
09/30/2022 10/27/2022 10-Q
06/30/2022 07/28/2022 10-Q
03/31/2022 04/28/2022 10-Q
12/31/2021 02/28/2022 10-K
09/30/2021 10/28/2021 10-Q
06/30/2021 07/29/2021 10-Q
03/31/2021 04/29/2021 10-Q
12/31/2020 02/26/2021 10-K
09/30/2020 10/29/2020 10-Q
06/30/2020 07/31/2020 10-Q
03/31/2020 04/30/2020 10-Q
12/31/2019 02/26/2020 10-K
09/30/2019 10/28/2019 10-Q
06/30/2019 07/26/2019 10-Q
			
		
	

	
		
			
				
				 Recent Forward Guidance [BETA]
				Latest: Q1 2026 Earnings Reported 5/4/2026
				Forward Guidance Guidance Change
Metric Low Mid High % Chg % Delta Change Prior
2026 Revenue 323.00 Mil 326.50 Mil 330.00 Mil 0   Affirmed Guidance: 326.50 Mil for 2026
2026 Net Income 20.40 Mil 21.60 Mil 22.80 Mil 0   Affirmed Guidance: 21.60 Mil for 2026
2026 Adjusted EBITDA 73.00 Mil 75.00 Mil 77.00 Mil 0   Affirmed Guidance: 75.00 Mil for 2026
2026 Capital Expenditures 31.00 Mil 32.50 Mil 34.00 Mil 0   Affirmed Guidance: 32.50 Mil for 2026
				Prior: Q4 2025 Earnings Reported 2/23/2026
				Forward Guidance Guidance Change
Metric Low Mid High % Chg % Delta Change Prior
2026 Revenue 323.00 Mil 326.50 Mil 330.00 Mil 8.6%   Higher New Actual: 300.50 Mil for 2025
2026 Net Income 20.40 Mil 21.60 Mil 22.80 Mil 3.4%   Higher New Actual: 20.90 Mil for 2025
2026 Adjusted EBITDA 73.00 Mil 75.00 Mil 77.00 Mil 6.4%   Higher New Actual: 70.50 Mil for 2025
2026 Capital Expenditures 31.00 Mil 32.50 Mil 34.00 Mil -3.0%   Lower New Actual: 33.50 Mil for 2025
			
		
	

	
		
			
				
				 Insider Activity
				Expand for More# Owner Title Holding Action Filing Date Price Shares Transacted
Value Value of
Held Shares Form
1 O'Hara, Kevin P Executive Vice President Direct Sell 5202026 24.08 3,000 72,230 505,173 Form
2 Cunningham, Jeff Chief Technology Officer Direct Sell 12102025 24.09 2,100 50,589 758,570 Form
3 O'Hara, Kevin P Executive Vice President Direct Sell 12082025 24.26 2,000 48,520 397,211 Form
4 Taylor, Tate Deborah   Direct Sell 12012025 25.46 1,580 40,227 588,813 Form
5 O'Hara, Kevin P Executive Vice President Direct Sell 8272025 27.97 2,000 55,936 479,286 Form
				Collapse to Preview# Owner Title Holding Action Filing Date Price Shares Transacted
Value Value of
Held Shares Form
1 O'Hara, Kevin P Executive Vice President Direct Sell 5202026 24.08 3,000 72,230 505,173 Form
2 Cunningham, Jeff Chief Technology Officer Direct Sell 12102025 24.09 2,100 50,589 758,570 Form
3 O'Hara, Kevin P Executive Vice President Direct Sell 12082025 24.26 2,000 48,520 397,211 Form
4 Taylor, Tate Deborah   Direct Sell 12012025 25.46 1,580 40,227 588,813 Form
5 O'Hara, Kevin P Executive Vice President Direct Sell 8272025 27.97 2,000 55,936 479,286 Form
			
		
	
	
	
		
			
				
				 HSTM Trade Sentinel
				
				
					
						
					
					
						
					
					
						
					
					
						
					
				
				
				
				
				
					
						
							
								
									
										Stock Conviction									
										null
									
								
								
									 
									 	CONVICTION RATIONALE
										null
									 
								
								
									
										
											STOCK ARCHETYPE
											null
										
										null
									
								
							

							
								Looking for high-conviction positions with a better risk/reward profile? See what's currently in the 
								Trefis High Quality Portfolio.
							

							
								
									
										INVESTMENT THESIS
										null
										null
										
										
											Mechanism:
											null
										
										
										
											Supporting Evidence:
											
												
											
										
									
								
								
								
									
										PRIMARY RISK
										null
										null
										
										 
											Mechanism:
											null
										
										
										
											Supporting Evidence:
											
												 
											
										
									
								
							

							
								 Key KPI Watchlist
								 
									
										
											
												
													KPI
													Threshold
													Rationale
												
											
											
												
											
										
									
								 
							

						
					

					
						
							
								Core Investment Debate
								
							

							
								
									
										BULL VIEW
										
									
								
								
									
										CORE TENSION
										
										
										PREVAILING SENTIMENT
										
										
									
								
								
									
										BEAR VIEW
										
									
								
							

							
								Next 6 months: Risks and Catalysts
								
									
										
											
												
													Timeline
													Event & Metric To Watch
												
											
											
												
											
										
									
								
							

							
								Key Events in Last 6 Months
								
									
										
											
												
													Date
													Event
													Stock Impact
												
											
											
												
											
										
									
								
							

							
								Risk Management
								
									
										
											 Position Sizing
											null
											null
											null
										
										
											 Diversification Alternatives
											
												
											
										
									
								
							
						
					

					
						
							How Is The Market Pricing HSTM?

							
								
									
								
							

							
								
									
								
							

							
								
									
										 What will confirm the thesis
										
									
								

								
									
										 What will damage the thesis
										
									
								

								
									
										 Noise: Real but irrelevant to thesis
										
									
								
							

							
								Repricing Catalyst
								
							

							
								What HSTM Makes & Who Pays

								
									
										TTM figures based on 
									
								
								
								
									
								
							

							
								HSTM Evolution: Price Return by Era
								
								
								

								
									
										
									
								
							

						
					

					
						
						
							
							
								
								

								
									
										① Structure
										
											0
											
										
										
									
									
										② Volume / Momentum
										
											0
											
										
										
									
									
										③ Catalyst
										
											0
											
										
										
									
								

								
									Combined Score
									
										
									
									0 / 12
								
							

							
								
									1
									Price Structure & Trend
									 · 
									▾
								
								
									
										▲
										
									

									
										
											Current
											$
											
											
										
										
											20D SMA
											$
											
											Below
										
										
											50D SMA
											$
											Slope: %
											Below
										
										
											200D SMA
											$
											Slope: %
											Below
										
									

									
										✕
										 —  trading days ago
									

									
										
											52W High
											$
										
										
											From 52W High
											%
										
										
											All-Time High
											$
										
										
											From ATH
											%
										
									
									
										
											52W Low
											$
										
										
											From 52W Low
											%
										
									
								
							

							
								
									2
									Momentum
									
									▾
								
								
									
										↑
										
									

									
										
											5D
											%
											
										
										
											20D
											%
											
										
										
											63D
											%
											
										
										
											126D
											%
											
										
										
											252D
											%
											
										
									
								
							

							
								
									3
									Relative Strength vs. SPY
									
									▾
								
								
									
										↑
										
									

									
										
											20D
											
											%
										
										
											63D
											
											%
										
										
											126D
											
											%
										
										
											252D
											
											%
										
									

									
										
											RS Trend
											%
										
										
											RS Character
											
										
									
								
							

							
								
									4
									Institutional Footprint & Volume
									
									▾
								
								
									
										↓
										
									
									
										◈
										
									

									
										
											Score
											
										
										
											Up/Down Vol 20D
											
										
										
											Up/Down Vol 60D
											
										
									
									
										
											OBV Slope 20D
											
										
										
											OBV Slope 60D
											
										
										
											Hi-Conv Up Days
											
											Past 60D
										
										
											Hi-Conv Down Days
											
											Past 60D
										
									
									
										
											Volume Trend
											
											20D avg vs 60D avg
										
										
									
								
							

							
								
									5
									Volatility
									
									▾
								
								
									
										≈
										
									
									
										
											HV 20D
											%
										
										
											HV 60D
											%
										
										
											HV 252D
											%
										
									
									
										
											Compression Ratio
											
										
										
											ATR 14D
											%
										
									
								
							

							
								
									6
									Key Price Levels
									Range · Vol 
									▾
								
								
									
										◈
										
									
									
										
											Nearest Resistance
											$
											% away ·  touches
										
										
											Nearest Support
											$
											% away ·  touches
										
										
											2nd Support
											$
											 touches
										
										
											Risk / Reward
											×
										
									
									
										
											Approach Volume
											
										
										
											Current Price
											$
										
									
								
							

							
								
									7
									Earnings Reaction History
									
									▾
								
								
									
										★
										
									
									
										
											
												
												
											
											
												%
												Earnings Day Return · Vol Spike ×
												
													
														5D
														%
													
													
														10D
														%
													
													
														20D
														%
													
													
														Post Vol
														×
													
												
												
												
											
										
										
											
												
												
											
											
												%
												Earnings Day Return · Vol Spike ×
												
													
														5D
														%
													
													
														10D
														%
													
													
														20D
														%
													
													
														Post Vol
														×
													
												
												
												
											
										
									
								
							

							
								
									8
									How the Verdict Is Derived
									Three Pillars
									▾
								
								
									
										
											
												Pillar
												Score
											
										
										
											
												① Structure
												0
											
											
												② Vol / Mom
												0
											
											
												③ Catalyst
												0
											
										
									
									
										ℹ
										
											Bull Pillars: 0 ·
											Bear Pillars: 0 ·
											Combined Score: 0 →
											
										
									
								
							

							
								Price Intelligence is derived from price-volume pattern analysis only. All moving averages are simple (SMA). Relative strength benchmarked against SPY.
							
						
					
					
				
			
		
	
	
	
		
			
				
				 Industry Resources
Health Care Resources
U.S. National Library of Medicine
ClinicalTrials.gov
Modern Healthcare
Healthcare Dive
Fierce Healthcare
Health Affairs
Health Data Management
FDA Tracker
			
		
		
			
				
				 External Quote Links
0 Y Finance Barrons
1 TradingView Morningstar
2 SeekingAlpha ValueLine
3 Motley Fool Robinhood
4 CNBC Etrade
5 MarketWatch Unusual Whales
6 YCharts Perplexity Finance
7 FinViz  

Prefer one of these to Trefis? Tell us why.

Pillar	Score
① Structure	0
② Vol / Mom	0
③ Catalyst	0

	Title	Date
0	DASHBOARDS
1	HealthStream Earnings Notes	12/16/2025
2	How Low Can HealthStream Stock Really Go?	10/17/2025
3	HealthStream (HSTM) Operating Cash Flow Comparison	02/17/2025
4	HealthStream (HSTM) Net Income Comparison	02/15/2025
5	HealthStream (HSTM) Operating Income Comparison	02/15/2025
6	HealthStream (HSTM) Revenue Comparison	02/13/2025

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
GEHC_4302026_Dip_Buyer_FCFYield	04302026	GEHC	GE HealthCare Technologies	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	0.0%	0.0%	0.0%
IQV_4302026_Dip_Buyer_FCFYield	04302026	IQV	IQVIA	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	0.0%	0.0%	0.0%
UHS_4302026_Dip_Buyer_FCFYield	04302026	UHS	Universal Health Services	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	0.0%	0.0%	0.0%
ABT_4302026_Dip_Buyer_ValueBuy	04302026	ABT	Abbott Laboratories	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	0.0%	0.0%	0.0%
ZBIO_4302026_Insider_Buying_45D_2Buy_200K	04302026	ZBIO	Zenas BioPharma	Insider	Insider Buys 45DStrong Insider Buying Companies with multiple insider buys in the last 45 days	0.0%	0.0%	0.0%

	HSTM	WDAY	ORCL	NOW	ADP	PAYX	Median
Name	HealthSt.	Workday	Oracle	ServiceN.	Automati.	Paychex
Mkt Price	23.81	128.14	192.08	102.13	225.31	97.00	115.13
Mkt Cap	0.7	32.5	552.0	105.7	90.5	34.8	62.7
Rev LTM	312	9,854	64,077	13,960	21,600	6,334	11,907
Op Inc LTM	23	1,156	20,678	1,876	5,727	2,337	2,106
FCF LTM	33	2,972	-24,736	4,624	4,841	2,090	2,531
FCF 3Y Avg	35	2,427	-2,222	3,800	4,190	1,875	2,151
CFO LTM	63	3,178	23,514	5,437	5,452	2,320	4,308
CFO 3Y Avg	64	2,656	20,833	4,626	4,765	2,064	3,641

$ Mil	2025	2024	2023
Subscription services	280	268	254
Professional services	11	11	13
Total	292	279	267

Market Price	$23.81
Market Cap ($ Bil)	0.7
First Trading Date	04/11/2000
Distance from 52W High	-18.4%
	50 Days	200 Days
DMA Price	$21.59	$23.82
DMA Trend	down	up
Distance from DMA	10.3%	-0.1%
	3M	1YR
Volatility	44.0%	29.6%
Downside Capture	15.45	85.99
Upside Capture	69.60	42.45
Correlation (SPY)	4.8%	20.4%

	1M	2M	3M	6M	1Y	3Y
Beta	0.08	0.37	0.31	0.38	0.67	0.56
Up Beta	-0.69	-0.51	-0.50	-0.16	0.29	0.43
Down Beta	-0.83	-1.05	-0.39	-0.23	0.43	0.42
Up Capture	43%	97%	71%	51%	38%	30%
Bmk +ve Days	15	22	31	66	141	428
Stock +ve Days	11	20	28	51	109	370
Down Capture	342%	119%	92%	99%	129%	94%
Bmk -ve Days	4	18	30	56	108	321
Stock -ve Days	11	23	35	73	139	373

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with HSTM
HSTM	-15.3%	29.6%	-0.55	-
Sector ETF (XLV)	16.0%	14.5%	0.80	17.8%
Equity (SPY)	29.5%	12.0%	1.86	20.6%
Gold (GLD)	35.5%	26.8%	1.11	-6.4%
Commodities (DBC)	42.9%	18.7%	1.77	-7.1%
Real Estate (VNQ)	15.2%	13.1%	0.82	21.5%
Bitcoin (BTCUSD)	-29.5%	41.7%	-0.73	5.1%

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with HSTM
HSTM	-1.3%	28.7%	-0.02	-
Sector ETF (XLV)	5.7%	14.7%	0.21	32.7%
Equity (SPY)	14.0%	17.0%	0.64	32.4%
Gold (GLD)	18.8%	18.0%	0.85	-1.9%
Commodities (DBC)	10.4%	19.4%	0.42	0.7%
Real Estate (VNQ)	3.8%	18.8%	0.10	31.6%
Bitcoin (BTCUSD)	12.2%	55.3%	0.42	12.6%

	Annualized Return	Annualized Volatility	Sharpe Ratio	Correlation with HSTM
HSTM	1.3%	31.9%	0.11	-
Sector ETF (XLV)	9.9%	16.5%	0.49	36.0%
Equity (SPY)	15.7%	17.9%	0.75	37.1%
Gold (GLD)	13.0%	16.0%	0.67	-0.3%
Commodities (DBC)	7.8%	17.9%	0.35	9.6%
Real Estate (VNQ)	5.5%	20.7%	0.23	31.7%
Bitcoin (BTCUSD)	67.2%	66.9%	1.06	12.8%

Short Interest: As Of Date	4302026
Short Interest: Shares Quantity	1.0 Mil
Short Interest: % Change Since 4152026	7.9%
Average Daily Volume	0.2 Mil
Days-to-Cover Short Interest	6.1 days
Basic Shares Quantity	29.4 Mil
Short % of Basic Shares	3.4%

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
5/4/2026	14.6%	8.8%
2/23/2026	4.0%	0.6%	-1.1%
11/3/2025	2.8%	-3.1%	-2.3%
8/4/2025	-1.2%	-0.3%	7.8%
5/5/2025	-19.3%	-17.4%	-14.6%
2/24/2025	0.1%	3.4%	-1.0%
10/21/2024	5.7%	1.8%	13.4%
7/22/2024	-4.0%	-4.2%	-7.7%
...
SUMMARY STATS
# Positive	12	10	6
# Negative	8	10	13
Median Positive	4.1%	3.4%	10.9%
Median Negative	-5.8%	-3.6%	-3.5%
Max Positive	14.9%	14.1%	16.3%
Max Negative	-19.3%	-17.4%	-14.6%

Report Date	Filing Date	Filing
03/31/2026	05/06/2026	10-Q
12/31/2025	02/27/2026	10-K
09/30/2025	11/06/2025	10-Q
06/30/2025	08/07/2025	10-Q
03/31/2025	05/09/2025	10-Q
12/31/2024	02/28/2025	10-K
09/30/2024	10/24/2024	10-Q
06/30/2024	07/25/2024	10-Q
03/31/2024	04/25/2024	10-Q
12/31/2023	02/26/2024	10-K
09/30/2023	10/26/2023	10-Q
06/30/2023	07/27/2023	10-Q
03/31/2023	04/27/2023	10-Q
12/31/2022	02/28/2023	10-K
09/30/2022	10/27/2022	10-Q
06/30/2022	07/28/2022	10-Q

Forward Guidance				Guidance Change
Metric	Low	Mid	High	% Chg	% Delta	Change	Prior
2026 Revenue	323.00 Mil	326.50 Mil	330.00 Mil	0		Affirmed	Guidance: 326.50 Mil for 2026
2026 Net Income	20.40 Mil	21.60 Mil	22.80 Mil	0		Affirmed	Guidance: 21.60 Mil for 2026
2026 Adjusted EBITDA	73.00 Mil	75.00 Mil	77.00 Mil	0		Affirmed	Guidance: 75.00 Mil for 2026
2026 Capital Expenditures	31.00 Mil	32.50 Mil	34.00 Mil	0		Affirmed	Guidance: 32.50 Mil for 2026

#	Owner	Title	Holding	Action	Filing Date	Price	Shares	Transacted Value	Value of Held Shares	Form
1	O'Hara, Kevin P	Executive Vice President	Direct	Sell	5202026	24.08	3,000	72,230	505,173	Form
2	Cunningham, Jeff	Chief Technology Officer	Direct	Sell	12102025	24.09	2,100	50,589	758,570	Form
3	O'Hara, Kevin P	Executive Vice President	Direct	Sell	12082025	24.26	2,000	48,520	397,211	Form
4	Taylor, Tate Deborah		Direct	Sell	12012025	25.46	1,580	40,227	588,813	Form
5	O'Hara, Kevin P	Executive Vice President	Direct	Sell	8272025	27.97	2,000	55,936	479,286	Form

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

HealthStream (HSTM)

Market Price (5/23/2026): $23.79 | Market Cap: $698.9 MilSector: Health Care | Industry: Health Care Technology

HealthStream (HSTM)

Market Price (5/23/2026): $23.79Market Cap: $698.9 MilSector: Health CareIndustry: Health Care Technology

Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.

Valuation, Metrics & Events

Price Chart

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

In The Past

Preserve Wealth

Asset Allocation

About HealthStream (HSTM)

Workforce Solutions Segment

Provider Solutions Segment

Capital Allocation Decisions for HealthStream (HSTM) over the Last 3-5 Years

Share Repurchases

Share Issuance

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets vs. HealthStream (HSTM)

INDUSTRY: Health Care Technology

Higher Rev Chg 3Y Avg | Lower P/S (Values for HSTM: 4.9% | 2.2x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for HSTM: 4.9% | 29.9x)

Higher Rev Chg LTM (Value for HSTM: 6.6%)

Higher Rev Chg 3Y Avg (Value for HSTM: 4.9%)

Higher Op Mgn LTM (Value for HSTM: 7.5%)

Higher CFO/Rev LTM (Value for HSTM: 20.3%)

Higher FCF/Rev LTM (Value for HSTM: 10.5%)

Higher Total Yield (Value for HSTM: 3.4%)

SECTOR: Health Care

Higher Rev Chg 3Y Avg | Lower P/S (Values for HSTM: 4.9% | 2.2x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for HSTM: 4.9% | 29.9x)

Higher Rev Chg LTM (Value for HSTM: 6.6%)

Higher Rev Chg 3Y Avg (Value for HSTM: 4.9%)

Higher Op Mgn LTM (Value for HSTM: 7.5%)

Higher CFO/Rev LTM (Value for HSTM: 20.3%)

Higher FCF/Rev LTM (Value for HSTM: 10.5%)

Higher Total Yield (Value for HSTM: 3.4%)

All Other Sectors

Higher Rev Chg 3Y Avg | Lower P/S (Values for HSTM: 4.9% | 2.2x)

Higher Rev Chg 3Y Avg | Lower P/Op Inc (Values for HSTM: 4.9% | 29.9x)

Higher Rev Chg LTM (Value for HSTM: 6.6%)

Higher Rev Chg 3Y Avg (Value for HSTM: 4.9%)

Higher Op Mgn LTM (Value for HSTM: 7.5%)

Higher CFO/Rev LTM (Value for HSTM: 20.3%)

Higher FCF/Rev LTM (Value for HSTM: 10.5%)

Higher Total Yield (Value for HSTM: 3.4%)

Best Bets in Health Care

P/EBIT (Value for HSTM: 29.9x)

P/E (Value for HSTM: 35.1x)

Rev Chg 3Y Avg (Value for HSTM: 4.9%)

Rev Chg LTM (Value for HSTM: 6.6%)

Rev Chg Q (Value for HSTM: 10.5%)

FCF/Rev 3Y Avg (Value for HSTM: 11.8%)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

Top Gainers

Top Losers

Top Gainers

Top Losers

Top Gainers

Top Losers

Market Price (5/23/2026): $23.79 | Market Cap: $698.9 Mil
Sector: Health Care | Industry: Health Care Technology

Market Price (5/23/2026): $23.79
Market Cap: $698.9 Mil
Sector: Health Care
Industry: Health Care Technology